Wells Fargo Maintains Overweight on Tenet Healthcare, Raises Price Target to $321
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $281 to $321.
Wells Fargo analyst Stephen Baxter maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $281 to $321.